Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer

Three weekly high-dose chemotherapy regimens in combination with weekly cetuximab are the treatment of choice for patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (SCCHN), although the majority of patients suffer from severe side effects. Thus, we investigated the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Hannah, Pammer, Johannes, Minichsdorfer, Christoph, Posch, Doris, Kornek, Gabriela, Aretin, Marie-Bernadette, Fuereder, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801394/
https://www.ncbi.nlm.nih.gov/pubmed/29411154
http://dx.doi.org/10.1007/s12032-018-1087-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801394/
https://www.ncbi.nlm.nih.gov/pubmed/29411154
http://dx.doi.org/10.1007/s12032-018-1087-6

Ejemplares similares